These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10552982)

  • 1. In-vitro activity of rifabutin and albendazole singly and in combination with other clinically used antimicrobial agents against Pneumocystis carinii.
    Cirioni O; Giacometti A; Barchiesi F; Fortuna M; Scalise G
    J Antimicrob Chemother; 1999 Nov; 44(5):653-9. PubMed ID: 10552982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of growth of Pneumocystis carinii by lactoferrins alone and in combination with pyrimethamine, clarithromycin and minocycline.
    Cirioni O; Giacometti A; Barchiesi F; Scalise G
    J Antimicrob Chemother; 2000 Oct; 46(4):577-82. PubMed ID: 11020255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro activity of atovaquone, sulphamethoxazole and dapsone alone and combined with inhibitors of dihydrofolate reductase and macrolides against Pneumocystis carinii.
    Cirioni O; Giacometti A; Scalise G
    J Antimicrob Chemother; 1997 Jan; 39(1):45-51. PubMed ID: 9044027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro activity of lytic peptides alone and in combination with macrolides and inhibitors of dihydrofolate reductase against Pneumocystis carinii.
    Cirioni O; Giacometti A; Barchiesi F; Scalise G
    J Antimicrob Chemother; 1998 Oct; 42(4):445-51. PubMed ID: 9818742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro activity of lytic peptides, inhibitors of ion transport systems and ionophorous antibiotics against Pneumocystis carinii.
    Cirioni O; Giacometti A; Barchiesi F; Scalise G
    J Antimicrob Chemother; 1998 Aug; 42(2):141-5. PubMed ID: 9738830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of terbinafine against Pneumocystis carinii in vitro and its efficacy in the treatment of experimental pneumonia.
    Contini C; Manganaro M; Romani R; Tzantzoglou S; Poggesi I; Vullo V; Delia S; De Simone C
    J Antimicrob Chemother; 1994 Nov; 34(5):727-35. PubMed ID: 7706168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture.
    Giacometti A; Cirioni O; Barchiesi F; Ancarani F; Scalise G
    J Antimicrob Chemother; 2000 Apr; 45(4):453-6. PubMed ID: 10747821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro activity of terbinafine, atovaquone and co-trimoxazole against Pneumocystis carinii.
    Cirioni O; Giacometti A; Balducci M; Burzacchini F; Scalise G
    J Antimicrob Chemother; 1995 Oct; 36(4):740-2. PubMed ID: 8591953
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment and prevention of Pneumocystis carinii pneumonia and further elucidation of the P. carinii life cycle with 1,3-beta-glucan synthesis inhibitor L-671,329.
    Schmatz DM; Powles M; McFadden DC; Pittarelli LA; Liberator PA; Anderson JW
    J Protozool; 1991; 38(6):151S-153S. PubMed ID: 1818147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages.
    Pellegrin I; Maugein J; Lapeyre C; Barbeau P; Leng B; Pellegrin JL
    J Antimicrob Chemother; 1996 Mar; 37(3):501-10. PubMed ID: 9182107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of clarithromycin and rifabutin alone and in combination on intracellular and extracellular replication of Mycobacterium avium.
    Mor N; Vanderkolk J; Mezo N; Heifets L
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2738-42. PubMed ID: 7695255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically used antimicrobial drugs against experimental pneumocystosis, singly and in combination: analysis of drug interactions and efficacies.
    Walzer PD; Runck J; Orr S; Foy J; Steele P; White M
    Antimicrob Agents Chemother; 1997 Feb; 41(2):242-50. PubMed ID: 9021174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clarithromycin, minocycline, and rifabutin treatments before and after infection of C57BL/6 mice with Mycobacterium avium.
    Lazard T; Perronne C; Grosset J; Vilde JL; Pocidalo JJ
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1690-2. PubMed ID: 8215285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro activity of polycationic peptides against Cryptosporidium parvum, Pneumocystis carinii and yeast clinical isolates.
    Giacometti A; Cirioni O; Barchiesi F; Caselli F; Scalise G
    J Antimicrob Chemother; 1999 Sep; 44(3):403-6. PubMed ID: 10511411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro activity of macrolides alone and in combination with artemisin, atovaquone, dapsone, minocycline or pyrimethamine against Cryptosporidium parvum.
    Giacometti A; Cirioni O; Scalise G
    J Antimicrob Chemother; 1996 Sep; 38(3):399-408. PubMed ID: 8889715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological profile and response to anti-pneumocystis agents of Pneumocystis carinii in cell culture.
    Pifer LL; Pifer DD; Woods DR
    Antimicrob Agents Chemother; 1983 Nov; 24(5):674-8. PubMed ID: 6607029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antiparasitic and antitumor activity of 2, 4-diamino-6-(arylmethyl)-5,6,7,8-tetrahydroquinazoline analogues of piritrexim.
    Rosowsky A; Papoulis AT; Forsch RA; Queener SF
    J Med Chem; 1999 Mar; 42(6):1007-17. PubMed ID: 10090784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of experimental Pneumocystis carinii infection by combination of clarithromycin and sulphamethoxazole.
    Alder J; Mitten M; Shipkowitz N; Hernandez L; Hui YH; Marsh K; Clement J
    J Antimicrob Chemother; 1994 Feb; 33(2):253-63. PubMed ID: 8182006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipneumocystis activity of water-soluble lipopeptide L-693,989 in rats.
    Schmatz DM; Powles MA; McFadden DC; Pittarelli L; Balkovec J; Hammond M; Zambias R; Liberator P; Anderson J
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1964-70. PubMed ID: 1416888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albendazole inhibits Pneumocystis carinii proliferation in inoculated immunosuppressed mice.
    Bartlett MS; Edlind TD; Lee CH; Dean R; Queener SF; Shaw MM; Smith JW
    Antimicrob Agents Chemother; 1994 Aug; 38(8):1834-7. PubMed ID: 7986016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.